Neurology News
🌏 NMPANMPA breaking news and regulatory updates for BD, investors, and analysts
Showing 1–12 of 13 articles
Lunai Bioworks Raises $20 Million to Acquire CNS Drug Delivery Technology for Alzheimer's Treatment
FDA Approves Travere's FILSPARI for FSGS Treatment in Adults and Children 8+
Keenova Therapeutics Presents New TERLIVAZ Clinical Data for Hepatorenal Syndrome at Digestive Disease Week 2026
Axoft Raises $55M Series A to Advance Brain-Computer Interface Clinical Trials Globally
Arcera Life Sciences Partners with Fosun Pharma for Neurodegenerative Disease R&D Collaboration
Immunic Appoints Dr. Michael Panzara as Chief Medical Officer to Lead Vidofludimus Calcium Development
Daewoong Pharmaceutical NABOTA Master Class Highlights PrabotulinumtoxinA Safety for High-Dose Treatments
Spinogenix Launches Phase 2b/3 CLARITY Trial of SPG601 for Fragile X Syndrome Treatment
SynSmart and Amporin Partner to Develop Small Molecule Therapeutics for Degenerative Diseases
P&G Health Launches First APAC Pharmacist Guidelines for Peripheral Neuropathy Management
Phantom Neuro Receives Approval for First Human Trial of Phantom X Neural Interface System
XellSmart Advances XS411 Parkinson's Cell Therapy to Phase II Trial After Positive Phase I Results